Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in taiwan

C. Y. Chiang, M. C. Yu, K. J. Bai, J. Suo, T. P. Lin, Y. C. Lee

研究成果: 雜誌貢獻文章同行評審

35 引文 斯高帕斯(Scopus)


SETTING: Chronic Disease Control Bureau, Department of Health, Taiwan. OBJECTIVE: To evaluate the role of pulmonary resection in the treatment of pulmonary tuberculosis resistant to isoniazid and rifampin (MDR-TB). DESIGN: In a retrospective cohort study, 27 MDR-TB patients who underwent pulmonary resection between December 1990 and March 1999 were reviewed. Individually-tailored treatment regimens were selected at a once-weekly staff conference following review of the patient's case history and drug susceptibility results. Surgery was performed for selected patients, essentially those: 1) whose medical treatment had failed, or for whom treatment failure seemed highly likely, or for whom post-treatment relapse seemed likely, 2) with predominantly localised disease, 3) with adequate cardiopulmonary reserve, and 4) whose treatment regimen had been composed of at least two effective drugs to diminish the mycobacterial burden. RESULTS: There was no surgical mortality apart from one peri-operative death (4%). Three patients (11%) developed complications, and 24 (92%) patients demonstrated sputum conversion and/or remained negative after surgery. Twenty-three patients have already completed treatment, and during a mean of 42 ± 18 follow-up months (range 15-80 months), one patient relapsed. This patient was disease-free after another course of treatment. CONCLUSION: For selected patients, pulmonary resection may improve the outcome of pulmonary MDR-TB.
頁(從 - 到)272-277
期刊International Journal of Tuberculosis and Lung Disease
出版狀態已發佈 - 2001

ASJC Scopus subject areas

  • 肺和呼吸系統醫學


深入研究「Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in taiwan」主題。共同形成了獨特的指紋。